Feasibility of a Type 1 Diabetes Primary Prevention Trial Using 2000 IU Vitamin D3 in Infants from the General Population with Increased HLA-Associated Risk
Article first published online: 9 NOV 2006
Annals of the New York Academy of Sciences
Volume 1079, Immunology of Diabetes IV: Progress in Our Understanding pages 310–312, October 2006
How to Cite
WICKLOW, B. A. and TABACK, S. P. (2006), Feasibility of a Type 1 Diabetes Primary Prevention Trial Using 2000 IU Vitamin D3 in Infants from the General Population with Increased HLA-Associated Risk. Annals of the New York Academy of Sciences, 1079: 310–312. doi: 10.1196/annals.1375.047
- Issue published online: 9 NOV 2006
- Article first published online: 9 NOV 2006
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!